SE9904581D0 - A novel helicobacter pylori-binding substance and use thereof - Google Patents

A novel helicobacter pylori-binding substance and use thereof

Info

Publication number
SE9904581D0
SE9904581D0 SE9904581A SE9904581A SE9904581D0 SE 9904581 D0 SE9904581 D0 SE 9904581D0 SE 9904581 A SE9904581 A SE 9904581A SE 9904581 A SE9904581 A SE 9904581A SE 9904581 D0 SE9904581 D0 SE 9904581D0
Authority
SE
Sweden
Prior art keywords
helicobacter pylori
binding substance
novel helicobacter
binding
identification
Prior art date
Application number
SE9904581A
Other languages
English (en)
Inventor
Karl-Anders Karlsson
Irene Leonardsson
Susann Teneberg
Jonas Aangstroem
Original Assignee
A & Science Invest Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A & Science Invest Ab filed Critical A & Science Invest Ab
Priority to SE9904581A priority Critical patent/SE9904581D0/sv
Publication of SE9904581D0 publication Critical patent/SE9904581D0/sv
Priority to HU0204243A priority patent/HUP0204243A3/hu
Priority to US10/149,608 priority patent/US20040086514A1/en
Priority to NZ520111A priority patent/NZ520111A/en
Priority to SK815-2002A priority patent/SK8152002A3/sk
Priority to AU24188/01A priority patent/AU783876B2/en
Priority to PL00356329A priority patent/PL356329A1/xx
Priority to JP2001544888A priority patent/JP2003517015A/ja
Priority to CA002392766A priority patent/CA2392766A1/en
Priority to PCT/SE2000/002567 priority patent/WO2001043751A1/en
Priority to EP00987920A priority patent/EP1237558A1/en
Priority to IL15024700A priority patent/IL150247A0/xx
Priority to CNB008172927A priority patent/CN100389773C/zh
Priority to EEP200200312A priority patent/EE200200312A/xx
Priority to RU2002118703/15A priority patent/RU2283115C2/ru
Priority to CZ20021989A priority patent/CZ20021989A3/cs
Priority to ZA200204251A priority patent/ZA200204251B/en
Priority to NO20022890A priority patent/NO20022890L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
SE9904581A 1999-12-15 1999-12-15 A novel helicobacter pylori-binding substance and use thereof SE9904581D0 (sv)

Priority Applications (18)

Application Number Priority Date Filing Date Title
SE9904581A SE9904581D0 (sv) 1999-12-15 1999-12-15 A novel helicobacter pylori-binding substance and use thereof
CZ20021989A CZ20021989A3 (cs) 1999-12-15 2000-12-15 Látka, která váľe Helicobacter pylori, farmaceutický prostředek je obsahující a její pouľití
CA002392766A CA2392766A1 (en) 1999-12-15 2000-12-15 Novel helicobacter pylori-binding substances and use thereof
EP00987920A EP1237558A1 (en) 1999-12-15 2000-12-15 Novel helicobacter pylori-binding substances and use thereof
NZ520111A NZ520111A (en) 1999-12-15 2000-12-15 Novel helicobacter pylori-binding substances and use thereof
SK815-2002A SK8152002A3 (en) 1999-12-15 2000-12-15 Novel helicobacter pylori-binding substances and use thereof
AU24188/01A AU783876B2 (en) 1999-12-15 2000-12-15 Novel helicobacter pylori-binding substances and use thereof
PL00356329A PL356329A1 (en) 1999-12-15 2000-12-15 Novel helicobacter pylori-binding substances and use thereof
JP2001544888A JP2003517015A (ja) 1999-12-15 2000-12-15 ヘリコバクターピロリ結合性新規物質およびその用途
HU0204243A HUP0204243A3 (en) 1999-12-15 2000-12-15 Novel helicobacter pylori-binding substances and use thereof
PCT/SE2000/002567 WO2001043751A1 (en) 1999-12-15 2000-12-15 Novel helicobacter pylori-binding substances and use thereof
US10/149,608 US20040086514A1 (en) 1999-12-15 2000-12-15 Novel helicobacter pylori-binding substances and use thereof
IL15024700A IL150247A0 (en) 1999-12-15 2000-12-15 Novel helicobacter pylori-binding substances and use thereof
CNB008172927A CN100389773C (zh) 1999-12-15 2000-12-15 新的能结合幽门螺杆菌的物质及其用途
EEP200200312A EE200200312A (et) 1999-12-15 2000-12-15 Uued Helicobacter pylori'ga seonduvad ained ja nende kasutamine
RU2002118703/15A RU2283115C2 (ru) 1999-12-15 2000-12-15 Новые вещества, связывающиеся с helicobacter pylori, и их применение
ZA200204251A ZA200204251B (en) 1999-12-15 2002-05-28 Novel helicobacter pylori-binding substances and use thereof.
NO20022890A NO20022890L (no) 1999-12-15 2002-06-17 Nye Heliobacter pylori-bindende substanser samt anvendelse derav

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9904581A SE9904581D0 (sv) 1999-12-15 1999-12-15 A novel helicobacter pylori-binding substance and use thereof

Publications (1)

Publication Number Publication Date
SE9904581D0 true SE9904581D0 (sv) 1999-12-15

Family

ID=20418126

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9904581A SE9904581D0 (sv) 1999-12-15 1999-12-15 A novel helicobacter pylori-binding substance and use thereof

Country Status (18)

Country Link
US (1) US20040086514A1 (sv)
EP (1) EP1237558A1 (sv)
JP (1) JP2003517015A (sv)
CN (1) CN100389773C (sv)
AU (1) AU783876B2 (sv)
CA (1) CA2392766A1 (sv)
CZ (1) CZ20021989A3 (sv)
EE (1) EE200200312A (sv)
HU (1) HUP0204243A3 (sv)
IL (1) IL150247A0 (sv)
NO (1) NO20022890L (sv)
NZ (1) NZ520111A (sv)
PL (1) PL356329A1 (sv)
RU (1) RU2283115C2 (sv)
SE (1) SE9904581D0 (sv)
SK (1) SK8152002A3 (sv)
WO (1) WO2001043751A1 (sv)
ZA (1) ZA200204251B (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904581D0 (sv) * 1999-12-15 1999-12-15 A & Science Invest Ab A novel helicobacter pylori-binding substance and use thereof
FI20010118A (sv) * 2001-01-19 2002-07-20 Carbion Oy Nya receptorer för helicobacter pylori och deras användning
FI20011403A (sv) * 2001-06-29 2002-12-30 Carbion Oy Förfarande och sammansättningar för behandling av magsjukdomar
AU2002352531A1 (en) * 2001-06-29 2003-03-03 Carbion Oy Use of at least one glycoinhibitor substance
EP1476454A1 (en) * 2002-01-18 2004-11-17 Biotie Therapies Corp. Binding epitopes for helicobacter pylori and use thereof
US6946451B2 (en) 2002-02-04 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Insulin secretion promoter
ES2649736T3 (es) * 2002-06-28 2018-01-15 Nestec S.A. Composiciones terapéuticas para usar en la profilaxis o el tratamiento de las diarreas
FI20021989A0 (sv) * 2002-11-06 2002-11-06 Halina Miller-Podraza Receptorer för Helicobacter pylori med hög affinitet och deras användning
WO2006094267A2 (en) * 2005-03-03 2006-09-08 Indiana University Research And Technology Corporation Permethylation of oligosaccharides
JP4677525B2 (ja) * 2005-08-23 2011-04-27 国立大学法人 長崎大学 ヘリコバクター・ピロリの空胞化毒素の検出試薬および検出方法
FR2906808B1 (fr) * 2006-10-10 2012-10-05 Univ Nantes Utilisation d'anticorps monoclonaux specifiques de la forme o-acetylee du ganglioside gd2 dans le traitement de certains cancers
JP5014018B2 (ja) * 2006-10-18 2012-08-29 旭化成ケミカルズ株式会社 ピロリ菌の抑制剤または静菌剤
WO2008084561A1 (ja) * 2007-01-12 2008-07-17 Shinshu University α－Ｎ－アセチルグルコサミニル結合単糖誘導体を含有するピロリ菌増殖抑制剤
EP2060257A1 (en) 2007-11-08 2009-05-20 Nestec S.A. Prevention and treatment of secondary infections following viral infection
GB0817908D0 (en) 2008-10-01 2008-11-05 Univ Ghent Blood group a/b/h determinant on type 1 core glycosphinglipids chain as recognition point for the fedf protein of f18-fimbriated enterotoxigenic
WO2010041746A1 (ja) * 2008-10-10 2010-04-15 財団法人野口研究所 ピロリ菌増殖抑制剤
EP2844301A2 (en) * 2012-05-04 2015-03-11 Ineb-instituto de Engenharia Biomédica Microspheres for treating helicobacter pylori infections

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1544908A (en) * 1975-07-08 1979-04-25 Chembiomed Ltd Artificial oligosaccharide antigenic determinants
US4464360A (en) * 1980-05-09 1984-08-07 Hakon Leffler Glycosphingalipids for inhibiting bacterial adherence
US4678747A (en) * 1983-02-18 1987-07-07 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies for detection of an H (O) blood group antigen
SE8304006D0 (sv) * 1983-07-15 1983-07-15 Karlsson Karl Anders Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling
DK17885D0 (da) * 1985-01-14 1985-01-14 Karlsson Karl Anders Antiviralt middel
US4971905A (en) * 1987-08-11 1990-11-20 Pacific Northwest Research Foundation Diagnosis of cancerous or precancerous conditions in human secretory epithelia by enzyme activity of β-1-3N-acetylglucosaminyltransferase
US4895838A (en) * 1988-03-09 1990-01-23 Trustees Of Boston University Method for provoking angiogenesis by administration of angiogenically active oligosaccharides
US4957741A (en) * 1988-08-02 1990-09-18 Angio-Medical Corp. Method for the treatment of gastric ulcer
MX9304638A (es) * 1992-07-31 1994-05-31 Neose Pharm Inc Composicion para tratar e inhibir las ulceras gastricas y duodenales.
US6406894B1 (en) * 1992-12-11 2002-06-18 Glycorex Ab Process for preparing polyvalent and physiologically degradable carbohydrate-containing polymers by enzymatic glycosylation reactions and the use thereof for preparing carbohydrate building blocks
EP0601417A3 (de) * 1992-12-11 1998-07-01 Hoechst Aktiengesellschaft Physiologisch verträglicher und physiologisch abbaubarer, Kohlenhydratrezeptorblocker auf Polymerbasis, ein Verfahren zu seiner Herstellung und seine Verwendung
US6300113B1 (en) * 1995-11-21 2001-10-09 New England Biolabs Inc. Isolation and composition of novel glycosidases
DE4408248A1 (de) * 1994-03-11 1995-09-14 Hoechst Ag Physiologisch verträgliche und physiologisch abbaubare Kohlenhydrat-Mimetika, ein Verfahren zur Herstellung und ihre Verwendung
US5679769A (en) * 1994-03-15 1997-10-21 Sloan-Kettering Institute For Cancer Research Synthesis of asparagine-linked glycopeptides on a polymeric solid support
CA2189356A1 (en) * 1994-05-02 1995-11-09 Ting Chi Wong Process for preparation of glycosides of tumor-associated carbohydrate antigens
US5965544A (en) * 1995-09-29 1999-10-12 Glycim Oy Synthetic multivalent sLex containing polylactosamines and methods for use
EP0886640B1 (en) * 1996-01-30 2007-03-21 GlycoMimetics, Inc. SIALYL-LEWISa AND SIALYL-LEWISx EPITOPE ANALOGUES
US6841543B1 (en) * 1996-01-31 2005-01-11 President And Fellows Of Harvard College Methods of inhibiting production of T helper type 2 cytokines in human immune cells
NZ333250A (en) * 1996-06-10 2000-05-26 Thomas Boren Helicobacter pylori blood group antigen binding adhesion protein
DE69739750D1 (de) * 1996-07-23 2010-03-18 Seikagaku Kogyo Co Ltd Neue laktosamin-oligosaccharide und verfahren zu ihrer herstellung
JPH1045602A (ja) * 1996-07-31 1998-02-17 Motoyasu Murakami ヘリコバクター・ピロリ接着阻害剤またはインターロイキン−８産生阻害剤
US6902903B1 (en) * 1996-12-19 2005-06-07 Chiron Corporation Helicobacter pylori diagnostics
US6410057B1 (en) * 1997-12-12 2002-06-25 Samyang Corporation Biodegradable mixed polymeric micelles for drug delivery
AU740342B2 (en) * 1997-12-12 2001-11-01 Samyang Corporation Biodegradable mixed polymeric micelles for gene delivery
JP4318765B2 (ja) * 1998-04-01 2009-08-26 雪印乳業株式会社 ピロリ菌感染防御剤
KR100460173B1 (ko) * 1998-12-11 2004-12-04 겐 코오포레이션 헬리코박터 파일로리 정착 억제제
US20010051349A1 (en) * 2000-02-17 2001-12-13 Glycominds Ltd. Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
US20030100508A1 (en) * 1999-02-24 2003-05-29 Maryline Simon Carbohydrate epitope mimic compounds and uses thereof
IL146510A0 (en) * 1999-05-18 2002-07-25 Univ Iowa Res Found Production of complex carbohydrates
AUPQ275799A0 (en) * 1999-09-10 1999-10-07 Luminis Pty Limited Recombinant bacterium expressing an oligosaccharide receptor mimic
FI19992070A (sv) * 1999-09-28 2001-03-28 Jari Natunen Nya fukosylerade oligosackarider och förfarande för deras framställning
SE9904581D0 (sv) * 1999-12-15 1999-12-15 A & Science Invest Ab A novel helicobacter pylori-binding substance and use thereof
FI20010118A (sv) * 2001-01-19 2002-07-20 Carbion Oy Nya receptorer för helicobacter pylori och deras användning
EP1417965A1 (en) * 2002-11-07 2004-05-12 Vereniging Voor Christelijk Wetenschappelijk Onderwijs C-type lectin binding molecules, identification and uses thereof
AU2005239963B2 (en) * 2004-05-11 2011-01-06 De Staat Der Nederlanden, Vertegenwoordigd Door De Minister Van Vws Neisseria meningitidis IgtB LOS as adjuvant
US20080261258A1 (en) * 2004-07-09 2008-10-23 Amaox, Inc. Immune Cell Biosensors and Methods of Using Same
WO2006093524A2 (en) * 2004-07-16 2006-09-08 The General Hospital Corporation Antigen-carbohydrate conjugates

Also Published As

Publication number Publication date
NO20022890L (no) 2002-08-15
SK8152002A3 (en) 2002-11-06
CN100389773C (zh) 2008-05-28
PL356329A1 (en) 2004-06-28
CA2392766A1 (en) 2001-06-21
RU2283115C2 (ru) 2006-09-10
IL150247A0 (en) 2002-12-01
NZ520111A (en) 2004-08-27
CZ20021989A3 (cs) 2002-10-16
HUP0204243A2 (hu) 2003-03-28
EP1237558A1 (en) 2002-09-11
HUP0204243A3 (en) 2003-08-28
AU2418801A (en) 2001-06-25
US20040086514A1 (en) 2004-05-06
NO20022890D0 (no) 2002-06-17
JP2003517015A (ja) 2003-05-20
RU2002118703A (ru) 2004-02-20
AU783876B2 (en) 2005-12-15
WO2001043751A1 (en) 2001-06-21
EE200200312A (et) 2003-06-16
ZA200204251B (en) 2003-05-28
CN1411376A (zh) 2003-04-16

Similar Documents

Publication Publication Date Title
SE9904581D0 (sv) A novel helicobacter pylori-binding substance and use thereof
RU2159761C2 (ru) Замещенные 4-биарилмасляные или 5-биарилпентановые кислоты или их производные, способы их получения, фармацевтическая композиция и способ лечения
ATE271060T1 (de) Verbindungen und pharmazeutische zusammensetzungen zur behandlung und prophylaxe bakterieller infektionen
HUP0203056A1 (hu) Vakcinakészítmény
WO2003080582A3 (de) Fredericamycin-derivate
BG102708A (en) 4-aminopyrimidine derivatives, medicamentous preparations containing them, their application and method for their preparation
ATE304358T1 (de) (s,s)-reboxetin zur behandlung von migränekopfschmerzen
ATE425248T1 (de) Arzneimittel zur behandlung von c. pneumoniae infektionen
BR0009163A (pt) Vacina
NO20030301L (no) Nye heteroarylderivater og anvendelse derav som farmasöytika
DK1206484T3 (da) Antipicornavirale forbindelser og sammensætninger, deres farmaceutiske anvendelser og materialer til deres syntese
BR0314511A (pt) Seleção e uso de bactérias de ácido lático para reduzir a inflamação causada por helicobater
DE60136826D1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
DE50010284D1 (de) Arzneimittel zur behandlung von bluthochdruck
HK1069995A1 (en) Water soluble extract from plant of solanum genus and the preparation process thereof, and pharmaceutical composition containing the water soluble extract
WO2000058475A3 (en) Streptococcus pneumoniae antigens
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
NO20013787D0 (no) Soyaekstrakt som inneholder lipider, fremgangsmåte for dets fremstilling og farmasöytiske og kosmetiske blandinger
TR200402230T4 (tr) O-ikameli 6-metil-tramadol-türevleri
BR0009592A (pt) Composição anti-diabética, e, método para tratamento de diabetes mellitus
ATE402158T1 (de) Flavonoid-derivat
BRPI0411245A (pt) composto, composição farmacêutica, uso de um composto, e, métodos para tratamento ou profilaxia de vìrus oncogênicos e para tratamento ou profilaxia de condições ou distúrbios devidos a infecção por hpv
TW200504051A (en) Novel acridine derivatives and their use as medicaments
WO2001014576A3 (en) Process and intermediates for the preparation of isoxazolecaroxamides and analogues
ATE460168T1 (de) Nicht-radioaktives strontiummittel zur behandlung von krebs